We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Exploring Developments in IgAN and FSGS
Howard Trachtman, MD, FASN
Richard Lafayette, MD, FACP
Incorporating Targeted Therapies in Treatment Planning for AAV
David Jayne, MD
Bernhard Hellmich, MD
The Underestimated Consequences of Uncontrolled Gout: Renal and Cardiovascular Implications
Richard Johnson, MD
Abdul Abdellatif, MD, FASN
John K. Botson, MD, RPh
Brittany Weber, MD, PhD
Can You Manage Patients With Uncontrolled Gout More Effectively?
Is Gout Hiding in the Nephrology Clinic?
What’s New About Gout? Rheumatology Perspective
Is Managing Gout in the Nephrology Clinic a Challenge?
What Are the Emerging Therapies for Managing Gout?
Should We Look for Gout in the Cardiology Clinic?
Gout Beyond the Joints: What’s the Hidden Danger?
What’s New About Gout? Nephrology Perspective
Center of the Target: Which Patients Are Most Likely to Develop Gout?
Treat or Refer: Who Is Responsible for Managing Gout?
Main Messages of New ESC Guidelines for CVD Management in Diabetes
Achieving Success in IgAN & FSGS
Siân Griffin, MD, PhD
Jürgen Floege, MD
Loreto Gesualdo, MD, FERA
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education